OMCL

Omnicell Inc

39.83

USD

OMCL Earnings Reports

Positive Surprise Ratio

OMCL beat 33 of 40 last estimates.

83%

Next Report

Date of Next Report

May 04, 2026

Estimate for Q1 26 (Revenue/ EPS)

$310.07M

$0.33

Implied change from Q4 25 (Revenue/ EPS)

-1.25%

-17.50%

Implied change from Q1 25 (Revenue/ EPS)

+14.98%

+26.92%

Omnicell Inc earnings per share and revenue

On Feb 05, 2026, OMCL reported earnings of 0.40 USD per share (EPS) for Q4 25, missing the estimate of 0.50 USD, resulting in a -20.98% surprise. Revenue reached 313.98 million, compared to an expected 319.66 million, with a -1.77% difference. The market reacted with a -16.30% price change (close before vs. close after earnings).

Looking ahead to Q1 26, 9 analysts forecast an EPS of 0.33 USD, with revenue projected to reach 310.07 million USD, implying an decrease of -17.50% EPS, and decrease of -1.25% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Enovis Corporation

Report Date

Feb 26, 2026 For Q4 25

Estimate

$0.83

Actual

$0.95

Surprise

+13.31%

Clover Health Investments, Corp

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.10

Actual

-$0.10

Surprise

+5.12%

Butterfly Network, Inc.

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.06

Actual

-$0.06

Surprise

+7.12%

Fulgent Genetics, Inc. Common Stock

Report Date

Feb 27, 2026 For Q4 25

Estimate

$0.03

Actual

$0.16

Surprise

+422.88%

SOPHiA GENETICS SA Ordinary Shares

Report Date

Mar 03, 2026 For Q4 25

Estimate

-$0.24

Actual

-$0.28

Surprise

-15.56%

Senseonics Holdings, Inc. Common Stock

Report Date

Mar 02, 2026 For Q4 25

Estimate

-$0.44

Actual

-$0.46

Surprise

-3.84%

MDxHealth SA Ordinary Shares

Report Date

Feb 26, 2026 For Q4 25

Estimate

-$0.12

Actual

-$0.17

Surprise

-32.30%

Pulmonx Corporation Common Stock

Report Date

Mar 04, 2026 For Q4 25

Estimate

-$0.39

Actual

-$0.25

Surprise

+37.47%

Veeva Systems Inc.

Report Date

Mar 04, 2026 For Q4 26

Estimate

$1.97

Actual

$2.06

Surprise

+4.48%

Privia Health Group, Inc. Common Stock

Report Date

Feb 26, 2026 For Q4 25

Estimate

$0.03

Actual

$0.07

Surprise

+96.08%

FAQ

What were Omnicell Inc's earnings and revenue for the latest quarter Q4 2025?

For Q4 2025, Omnicell Inc reported EPS of $0.40, missing estimates by -20.98%, and revenue of $313.98M, -1.77% below expectations.

How did the market react to Omnicell Inc's Q4 2025 earnings?

The stock price moved down -16.3%, changed from $46.69 before the earnings release to $39.08 the day after.

When is Omnicell Inc expected to report next?

The next earning report is scheduled for May 04, 2026.

What are the forecasts for Omnicell Inc's next earnings report?

Based on 9 analysts, Omnicell Inc is expected to report EPS of $0.33 and revenue of $310.07M for Q1 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.